Epilepsy News

LOS ANGELES — A novel automated data-extraction tool successfully tracked daily antiseizure medication changes for individuals requiring long-term monitoring for epilepsy, data show.

LOS ANGELES — For those newly diagnosed with focal epilepsy and given antiseizure medications, most will be sensitive to treatment, with seizure freedom likely to occur after the first year of administration, according to a presenter.

LOS ANGELES — Researchers used data-driven modeling techniques to identify variables that significantly impact pre-surgical consultations for patients with epilepsy, which could lead to more streamlined service by health care providers.

LOS ANGELES — Adults with epilepsy performed worse on a facial and emotional recognition test compared with healthy controls, with the largest disparity in recognizing anger and fear, according to a poster.

LOS ANGELES — A novel electronic system may help clinicians remotely track patients in an epilepsy monitoring unit and prevent adverse events, according to a poster from the American Epilepsy Society annual meeting.

LOS ANGELES — U.S. veterans with epilepsy were more likely to adhere to a 90-day supply of antiseizure medication vs. a 30-day supply, resulting in fewer breakthrough seizures and a successful policy change within the VA, researchers reported.

LOS ANGELES — Individuals with epilepsy who used marijuana had a reduced length of hospitalization as well as a higher rate of epilepsy event capturability compared with those who did not use marijuana, data show.

LOS ANGELES — Introduction of a ketogenic diet reduced seizure burden in children with Aicardi syndrome as soon as 3 months, with beneficial long-term effects, according to a poster at the American Epilepsy Society annual meeting.

LOS ANGELES — An AI model accurately detected epileptic spasms in infants through smartphone videos, representing a “highly accessible approach” to accelerating diagnosis, according to researchers.

LOS ANGELES — Individuals with hypertension and stroke who were prescribed angiotensin receptor blockers had a significantly lower risk for post-stroke epilepsy than those prescribed other antihypertension medications, according to new research.